(MENAFN- PR Newswire) FRANKLIN LAKES, N.J., Feb. 2, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that new clinical ...
Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with ...
Inserting, monitoring, and maintaining peripheral venous access is an integral component of neonatal nursing care. Although complications associated with peripheral vascular devices are typically ...
BETHLEHEM, Pa., April 29, 2021 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today unveiled Peripheral Advantage (R), a new program that is ...
BETHLEHEM, Pa., Sept. 29, 2022 /PRNewswire/ -- Today B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, together with the Association for Vascular Access (AVA), ...
VOL: 103, ISSUE: 12, PAGE NO: 30-31 Jacqueline Randle, PhD, MSc, BA, PGDip, RN, RNT, PGCert Associate professor, Faculty of Medicine and Health Sciences, University ...
Peripheral Advantage ® Program Empowers Healthcare Providers and Improves Patients' Experiences with Intravenous Therapies BETHLEHEM, Pa., Oct. 13, 2023 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun ...
- There is robust evidence that the BD vascular care solution and skin antiseptic for peripheral intravenous catheters used in the CLEAN3 randomized clinical trial can help improve patient outcomes - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback